Discover life science companies across the East of England, including biotechnology firms, CROs, research organisations and innovation hubs.
Autonomous cell culture systems with integrated laboratory automation
Aixcell is a laboratory equipment company developing autonomous systems for mammalian cell culture and cell-based research. Its integrated platform brings together liquid handling, incubation, microscopy, refrigerated storage and labware management to run cell culture protocols with automated documentation.…
Veterinary vaccine CDMO and aquaculture diagnostics for animal health
Marinnovac UK is a contract research and manufacturing organisation specialising in veterinary vaccine development and viral antigen production for animal and aquaculture health applications. The company holds the only VMD-approved viral autogenous vaccine manufacturing licence in the UK, offering services spanning…
Specialist reagent and custom service supplier
AMSBIO supplies research products and custom services to biological and pharmaceutical research organisations. Its product portfolio covers cell culture systems including three-dimensional culture models, glycobiology reagents, ELISA kits, lentiviral tools, and stem cell research products. The company also provides…
RNAi brain shuttle platform for neurodegenerative disease drug delivery
Aerska is a biotechnology company developing RNA interference medicines to treat, delay and prevent diseases of the brain. The company's antibody oligonucleotide conjugate platform acts as a brain shuttle, enabling RNAi therapeutics to cross the blood brain barrier and reach the central nervous system through systemic…
CDMO and CRO for complex biologics and bioconjugate development
Abzena is an integrated CDMO and CRO specialising in complex biologics and bioconjugates, with cGMP facilities across the United States and a research presence in Cambridge, UK. Its services span antibody discovery, cell line development, bioconjugation and GMP manufacturing across monoclonal antibodies, antibody-drug…
Antibodies, proteins and assay reagents for life science research
Abbexa is a Cambridge-based supplier of biological research reagents serving academic, pharmaceutical and biotechnology customers worldwide. The company manufactures and distributes a broad catalogue of immunological and biochemical tools used in laboratory research, including primary and secondary antibodies,…
Integrated contract drug discovery from Cambridge and India
o2h is a contract research organisation operating an integrated drug discovery platform from Cambridge, UK, and Ahmedabad, India. Core services span medicinal chemistry, biology, DMPK, and non-GMP scale-up, supporting hit-to-lead optimisation through to IND-enabling studies. The company works across small molecule,…
Enzymatic DNA synthesis for pharmaceutical and biotechnology research
Camena Bioscience is a synthetic biology company that develops and supplies enzymatic gene synthesis technology to pharmaceutical and biotechnology customers. Its multi-enzymatic approach to DNA synthesis offers substantially improved accuracy and access to longer, more complex sequences compared to conventional…
Laboratory consumables and equipment supplier for research facilities
Optimaze is a laboratory consumables and equipment supplier providing research facilities with pipette tips, plates, instruments, and related lab supplies. The company stocks products for next-working-day dispatch and sources surplus laboratory equipment to offer cost-effective solutions to research organisations. It…
Non-endoscopic molecular diagnostics for early oesophageal cancer detection
Cyted Health is a gastrointestinal molecular diagnostics company developing minimally invasive testing for early detection and monitoring of oesophageal pre-cancer and cancer. Its platform combines a swallowable capsule sponge cell collection device with AI-driven biomarker molecular assays to detect Barrett's…
Phenotypic screening platform for targeted protein degradation drug discovery
PhoreMost is a drug discovery company developing a phenotypic screening platform to identify and prosecute previously undruggable disease targets. The platform systematically unmasks cryptic binding sites across the human proteome and links them to therapeutic functions in a live-cell context, enabling the discovery…
Targeting mitochondrial dysfunction in neurodegeneration
NRG Therapeutics is a clinical-stage neuroscience company developing small molecule inhibitors of the mitochondrial permeability transition pore as disease-modifying treatments for neurodegenerative disorders. Its lead candidate, NRG5051, entered Phase 1 clinical trials in January 2026 for ALS and Parkinson's disease.…
Next-generation sequencing and genomic analysis services
Novogene (UK) is a genomic services provider operating as the European hub of Novogene Corporation, one of the world's largest sequencing organisations. Based at Cambridge Science Park, the company offers a comprehensive range of next-generation sequencing services including whole genome, exome, RNA, single-cell,…
Microfluidic nanoparticle formulation instruments for gene and cell therapy
Unchained Labs (Royston) is a developer of microfluidic mixing instruments for nanoparticle and lipid nanoparticle formulation, spanning early-stage screening through GMP-ready production. The site's technology, developed from decades of microfluidics expertise, supports researchers formulating and scaling lipid…
End-to-end production systems for cultivated meat
Cellcraft is a biotechnology company developing integrated systems for cultivated meat production. The company supplies the hardware, software, and biological inputs required to grow animal cells outside the body at commercial scale, targeting food producers and manufacturers seeking slaughter-free protein production.…
Causal cellular data and AI models for drug discovery
CellCodex is a biotechnology company that generates causal data from human cells to train predictive models for drug discovery. It programmes stem cells into pure, aged, disease-relevant cell types, perturbs them at genome scale with CRISPR and compounds, and reads the outcome in single cells. The company applies the…
Dual-pathway AAV gene therapies for retinal degeneration
Ikarovec is a biotechnology company developing dual-pathway adeno-associated virus gene therapies for retinal diseases. Its lead candidate combines complementary mechanisms targeting complement activity, inflammation and retinal cell protection in geographic atrophy. Additional programmes target wet and intermediate…
Targeted oncology combination therapies in biomarker-defined cancer populations
Mosaic Therapeutics is a Cambridge biotech developing targeted combination therapies for cancer. Its proprietary platform integrates genome-scale CRISPR screening, high-throughput combination drug testing across over 1,300 patient-derived tumour models, and advanced computational analysis to identify synergistic drug…
Anti-inflammatory drugs for neurodegenerative disease
Sitala Bio is a Cambridge-based biotech developing small molecule drugs that target chronic neuroinflammation in conditions such as Parkinson's and Alzheimer's disease. The company's approach focuses on blocking microglial dysfunction to restore toxin clearance in the brain. Founded by NLRP3 inflammasome expert Matt…
Human iPSC models and AI phenomics for drug discovery
Pixl Bio combines human induced pluripotent stem cell (iPSC) models with AI-driven image analysis for drug discovery and safety research. Its portfolio includes liver cells, stellate cells and disease models, alongside CRISPR engineering, high-content Cell Painting and contract studies. These tools help researchers…